Skip to main content

Table 1 Clinical, biochemical and hematologic parameters (n = 47 patients)

From: Early outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional hemodialysis patients: a cross-sectional study

Height (cm)

167 ± 11

Weight (kg)

73 ± 20

Dialysis vintage (months)

44 ± 44

Diabetes mellitus

45 %

History of coronary artery disease

28 %

History of cerebrovascular disease

6 %

History of peripheral vascular disease

17 %

AV fistula

68 %

Supine pre-dialysis systolic blood pressure (mmHg)

143 ± 17

Supine pre-dialysis diastolic blood pressure (mmHg)

79 ± 9

Standing pre-dialysis systolic blood pressure (mmHg)

147 ± 20

Standing pre-dialysis diastolic blood pressure (mmHg)

83 ± 10

Inter-dialytic weight gain (L)

2.7 ± 0.9

Medication use

 

  ASA

62 %

  ACE inhibitor

42 %

  Angiotensin II receptor blocker

49 %

  Statin

51 %

  ESA

98 %

PRU

74 ± 10 %

Plasma albumin (g/L)

34 ± 5

Plasma calcium (mmol/L)

2.16 ± 0.20

Plasma phosphate (mmol/L)

1.75 ± 0.53

Plasma alkaline phosphatase (IU/L)

153 ± 210

Hemoglobin (g/L)

113 ± 12

Plasma ferritin (pM)

396 ± 313

Total iron saturation

24 ± 11 %

Fasting total cholesterol (mmol/L)

4.03 ± 0.70

Fasting LDL cholesterol (mmol/L)

2.01 ± 0.43

Fasting HDL cholesterol (mmol/L)

1.09 ± 0.30

Fasting triglycerides (mmol/L)

2.08 ± 1.15

  1. Values are Mean (or median) +/− SD (or interquartile range)
  2. PRU Percent reduction of Urea